{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.141","meta":{"versionId":"6","lastUpdated":"2021-03-06T01:00:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.141","version":"20210306","name":"Ondansetron Injectable","status":"active","date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1314133","display":"2 ML ondansetron 2 MG/ML Prefilled Syringe"},{"code":"1740467","display":"2 ML ondansetron 2 MG/ML Injection"},{"code":"283504","display":"ondansetron 2 MG/ML Injectable Solution"}]}]},"expansion":{"identifier":"urn:uuid:84660e0f-0d1d-41af-b8fd-dd78ea03832c","timestamp":"2022-06-10T10:28:33-04:00","total":3,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1314133","display":"2 ML ondansetron 2 MG/ML Prefilled Syringe"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1740467","display":"2 ML ondansetron 2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"283504","display":"ondansetron 2 MG/ML Injectable Solution"}]}}